Meloxicam Injectable solution (IM, IV) bulk supplier for pharma manufacturers

Meloxicam Injectable Solution (Im, Iv) 0.5 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (IM, IV)

Available Strengths: 0.5 mg/mL

Reference Brands: Metacam(US)

Meloxicam injectable is an NSAID that inhibits cyclooxygenase enzymes, reducing prostaglandin production, which alleviates pain, inflammation, and fever in animals. It provides rapid, effective relief, supporting recovery, improving mobility, and enhancing animal welfare, especially in post-surgical or inflammatory conditions when used as directed.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Meloxicam injectable is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves rigorous clinical data, primarily for pain and inflammation management in animals. In the EU, CE marking certifies conformity with veterinary medicinal regulations. These products undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial outcomes, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective meloxicam formulations vital for animal welfare and recovery worldwide.

Meloxicam Injectable Solution (Im, Iv) — third party manufacturing & bulk supply

Meloxicam Injectable Solution (Im, Iv) 0.5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Meloxicam Injectable Solution (Im, Iv) is supplied as Injectable solution (IM, IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Meloxicam Injectable Solution (Im, Iv) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Meloxicam Injectable Solution (Im, Iv) →

Back to Listing

Frequently Asked Questions

Meloxicam injection is used for the treatment of pain and inflammation associated with musculoskeletal disorders, post-operative pain, and conditions such as lameness. It is widely used in animals for managing inflammation and pain in conditions affecting joints, soft tissues, and after surgical procedures.

Meloxicam injection is made from meloxicam, an NSAID that works by inhibiting cyclooxygenase (COX) enzymes, particularly COX-2, thereby reducing the production of prostaglandins responsible for pain, inflammation, and fever.

Common trade names include Metacam, Melonex, Loxicom, Melovet, and various meloxicam injections marketed by different manufacturers.

Meloxicam injection is manufactured by multiple pharmaceutical companies globally, including Boehringer Ingelheim, Intas Pharmaceuticals, Zoetis, and other veterinary-focused and generic manufacturers.

The generic name is meloxicam.

Brand names include Metacam, Melonex, Loxicom, Melovet, and other region-specific generics.

Meloxicam injection is manufactured worldwide, with major production in India, Europe, and the United States by various pharmaceutical companies, including those specializing in animal health products.